These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 14558293)

  • 21. Atrial fibrillation: from ion channels to bedside treatment options.
    Singh B
    J Electrocardiol; 2009; 42(6):660-70. PubMed ID: 19520377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of action of antiarrhythmics in cardioversion of atrial fibrillation and atrial flutter].
    Davy JM; Raczka F; Beck L; Piot C
    Arch Mal Coeur Vaiss; 2003 May; 96 Spec No 4():20-9. PubMed ID: 12852282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action of class III agents and their clinical relevance.
    Dorian P
    Europace; 2000 Jul; 1 Suppl C():C6-9. PubMed ID: 11220521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antiarrhythmic drugs for prevention of atrial fibrillation.
    Goldstein RN; Stambler BS
    Prog Cardiovasc Dis; 2005; 48(3):193-208. PubMed ID: 16271945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
    Dobrev D; Nattel S
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].
    Ravens U; Wettwer E; Schotten U; Wessel R; Dobrev D
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):64-72. PubMed ID: 16786464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs that interact with cardiac electro-mechanics: old and new targets for treatment.
    Kirchhof P; Fortmüller L; Waldeyer C; Breithardt G; Fabritz L
    Prog Biophys Mol Biol; 2008; 97(2-3):497-512. PubMed ID: 18406454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on atrial remodelling owing to rate; does atrial fibrillation always 'beget' atrial fibrillation?
    Pandozi C; Santini M
    Eur Heart J; 2001 Apr; 22(7):541-53. PubMed ID: 11259142
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation: basic and clinical research at the Montreal Heart Institute.
    Roy D; Talajic M; Dubuc M; Thibault B; Guerra PG; Macle L; Gagné P; Khairy P; Nattel S
    Can J Cardiol; 2005 Oct; 21(12):1091-6. PubMed ID: 16234895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ionic currents and ventricular fibrillation dynamics].
    Moreno J; Warren M; Jalife J
    Rev Esp Cardiol; 2004 Jan; 57(1):69-79. PubMed ID: 14746720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.